Avid Bioservices Inc (CDMO)

[Fire Fox]

Speaking of the Imaging Trial,

I just discovered that the imaging trial started enrolling patients at least as early as June 28. You can confirm this fact by going to www.clinicaltrials.gov and searching for "PGN650" .

If you search for Bavituximab, the imaging trial won't come up. That's because the fully-human Bavituximab therapy molecule is PGN635, but to do the imaging trial they had to cut off the FC receptor on the tail of the MAB so that it would not cause a therapeutic effect when only a PS imaging effect is desired. The new truncated imaging molecule is called PGN650.

I don't why there was no PR announcing the start of enrollment of this trial.